U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07057323) titled 'Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure' on June 26.
Brief Summary: The purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Heart Failure Preserved Ejection Fraction
Intervention:
DEVICE: Coronary Sinus Reducer
Subjects will have the Coronary Sinus Reducer implanted in their coronary sinus during a right heart catheterization procedure.
Recruitment Status: NOT_YET_...